Claudia Palena

7.8k total citations
94 papers, 6.0k citations indexed

About

Claudia Palena is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Claudia Palena has authored 94 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 60 papers in Immunology and 27 papers in Molecular Biology. Recurrent topics in Claudia Palena's work include Immunotherapy and Immune Responses (47 papers), Cancer Immunotherapy and Biomarkers (40 papers) and Cancer Cells and Metastasis (33 papers). Claudia Palena is often cited by papers focused on Immunotherapy and Immune Responses (47 papers), Cancer Immunotherapy and Biomarkers (40 papers) and Cancer Cells and Metastasis (33 papers). Claudia Palena collaborates with scholars based in United States, Argentina and Italy. Claudia Palena's co-authors include Jeffrey Schlom, Duane H. Hamilton, Romaine I. Fernando, Justin M. David, Charli Dominguez, Mary Litzinger, James W. Hodge, Lucas A. Horn, Kwong-Yok Tsang and Kristen Fousek and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Claudia Palena

92 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Palena United States	43	3.5k	3.1k	1.9k	968	626	94	6.0k
Vincent Ling United States	28	3.6k 1.0×	4.9k 1.6×	1.4k 0.7×	558 0.6×	284 0.5×	49	7.6k
Masao Seto Japan	47	2.6k 0.7×	2.1k 0.7×	3.6k 1.9×	675 0.7×	1.9k 3.1×	239	8.5k
Fathia Mami‐Chouaib France	47	3.7k 1.1×	4.8k 1.6×	2.2k 1.1×	542 0.6×	1.2k 2.0×	107	7.9k
Masatoshi Tagawa Japan	35	1.7k 0.5×	1.5k 0.5×	2.3k 1.2×	418 0.4×	564 0.9×	210	4.6k
Ilaria Malanchi United Kingdom	26	2.5k 0.7×	1.3k 0.4×	2.6k 1.3×	457 0.5×	1.0k 1.6×	44	5.4k
Emma Di Carlo Italy	45	2.9k 0.8×	4.0k 1.3×	1.8k 0.9×	401 0.4×	500 0.8×	125	6.1k
Yasuharu Nishimura Japan	44	1.8k 0.5×	3.0k 1.0×	2.6k 1.4×	302 0.3×	386 0.6×	171	6.0k
Yoshito Ueyama Japan	41	2.6k 0.7×	1.3k 0.4×	3.2k 1.7×	748 0.8×	1.0k 1.6×	198	6.5k
Ali O. Güre United States	34	1.7k 0.5×	3.5k 1.1×	3.9k 2.0×	407 0.4×	907 1.4×	70	6.3k

Countries citing papers authored by Claudia Palena

Since Specialization

Citations

This map shows the geographic impact of Claudia Palena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Palena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Palena more than expected).

Fields of papers citing papers by Claudia Palena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Palena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Palena. The network helps show where Claudia Palena may publish in the future.

Co-authorship network of co-authors of Claudia Palena

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Palena. A scholar is included among the top collaborators of Claudia Palena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Palena. Claudia Palena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schlom, Jeffrey, Renee N. Donahue, Claudia Palena, et al.. (2024). Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines. Journal for ImmunoTherapy of Cancer. 12(7). e009595–e009595.

Horn, Lucas A., Hanne Lind, Kristen Fousek, et al.. (2024). Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models. Journal of Experimental & Clinical Cancer Research. 43(1). 318–318. 4 indexed citations

Minnar, Christine M., Paul L. Chariou, Lucas A. Horn, et al.. (2022). Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies. Journal for ImmunoTherapy of Cancer. 10(6). e004561–e004561. 34 indexed citations

Bilušić, Marijo, Sheri McMahon, Ravi A. Madan, et al.. (2021). Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal for ImmunoTherapy of Cancer. 9(3). e002374–e002374. 43 indexed citations

Horn, Lucas A., Kristen Fousek, & Claudia Palena. (2020). Tumor Plasticity and Resistance to Immunotherapy. Trends in cancer. 6(5). 432–441. 95 indexed citations

Greene, Sarah, Yvette Robbins, Wojciech K. Mydlarz, et al.. (2019). Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Clinical Cancer Research. 26(6). 1420–1431. 217 indexed citations

Lee, Karin L., Stephen C. Benz, Kristin C. Hicks, et al.. (2019). Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy. Cancer Immunology Research. 7(8). 1359–1370. 20 indexed citations

Gatti‐Mays, Margaret E., Julius Strauss, Renee N. Donahue, et al.. (2019). A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules. Clinical Cancer Research. 25(16). 4933–4944. 45 indexed citations

Heery, Christopher R., Claudia Palena, Sheri McMahon, et al.. (2017). Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury. Clinical Cancer Research. 23(22). 6833–6845. 51 indexed citations

10.

Hamilton, Duane H., Lesley A. Mathews Griner, Jonathan M. Keller, et al.. (2016). Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer. Clinical Cancer Research. 22(24). 6204–6216. 48 indexed citations

11.

Hamilton, Duane H., Mario Roselli, Patrizia Ferroni, et al.. (2016). Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer. Endocrine Related Cancer. 23(10). 783–796. 27 indexed citations

12.

Dominguez, Charli, Kwong-Yok Tsang, & Claudia Palena. (2016). Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies. Cell Death and Disease. 7(9). e2380–e2380. 38 indexed citations

13.

Hamilton, Duane H., et al.. (2014). WEE1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial–Mesenchymal Transition. Cancer Research. 74(9). 2510–2519. 70 indexed citations

14.

Ardiani, Andressa, Sofia R. Gameiro, Claudia Palena, et al.. (2014). Vaccine-Mediated Immunotherapy Directed against a Transcription Factor Driving the Metastatic Process. Cancer Research. 74(7). 1945–1957. 29 indexed citations

15.

Schlom, Jeffrey, James W. Hodge, Claudia Palena, et al.. (2014). Therapeutic Cancer Vaccines. Advances in cancer research. 121. 67–124. 68 indexed citations

16.

Larocca, Cecilia, et al.. (2013). An Autocrine Loop between TGF-β1 and the Transcription Factor Brachyury Controls the Transition of Human Carcinoma Cells into a Mesenchymal Phenotype. Molecular Cancer Therapeutics. 12(9). 1805–1815. 53 indexed citations

17.

Roselli, Mario, Romaine I. Fernando, Fiorella Guadagni, et al.. (2012). Brachyury, a Driver of the Epithelial–Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer. Clinical Cancer Research. 18(14). 3868–3879. 102 indexed citations

18.

Fernando, Romaine I., Marianne D. Castillo, Mary Litzinger, Duane H. Hamilton, & Claudia Palena. (2011). IL-8 Signaling Plays a Critical Role in the Epithelial–Mesenchymal Transition of Human Carcinoma Cells. Cancer Research. 71(15). 5296–5306. 319 indexed citations

19.

Gulley, James L., Philip M. Arlen, Kwong-Yok Tsang, et al.. (2008). Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma. Clinical Cancer Research. 14(10). 3060–3069. 176 indexed citations

20.

Arlen, Philip M., et al.. (2003). A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen-presenting cells expressing vector-driven human B7-1. Journal of Immunological Methods. 279(1-2). 183–192. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact